Dr. Kristin Higgins, MD
Claim this profileEmory University Hospital Midtown
Studies Lung Cancer
Studies Small Cell Lung Cancer
10 reported clinical trials
30 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Small Cell Lung Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Kristin Higgins, MD is currently running
Lurbinectedin + Radiotherapy
for Small Cell Lung Cancer
This phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung cancer that has spread outside of the chest and that has grown after being treated with chemotherapy (extensive stage). Lurbinectedin kills tumor cells by blocks a process called transcription that small cell lung cancer relies on to survive. It also damages the deoxyribonucleic acid (DNA) of tumor cells, which is similar to the way radiation kills tumor cells. Palliative radiotherapy is a routine medical treatment for patients who have lung cancer that has spread to other parts of the body (metastatic), and is used to relieve symptoms caused by cancer or to patients from developing symptoms. This trial may help doctors understand if treating patients with lurbinectedin and palliative radiotherapy at the same time would make them both work better than either one alone or if they could cause more side effects for patients when given together.
Recruiting2 awards Phase 116 criteria
Proton Therapy
for Small Cell Lung Cancer
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
Recruiting1 award N/A3 criteria
More about Kristin Higgins, MD
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Kristin Higgins, MD has experience with
- Carboplatin
- Atezolizumab
- Radiation Therapy
- Etoposide
- Cisplatin
- Durvalumab
Breakdown of trials Kristin Higgins, MD has run
Lung Cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kristin Higgins, MD specialize in?
Kristin Higgins, MD focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kristin Higgins, MD currently recruiting for clinical trials?
Yes, Kristin Higgins, MD is currently recruiting for 6 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Kristin Higgins, MD has studied deeply?
Yes, Kristin Higgins, MD has studied treatments such as Carboplatin, Atezolizumab, Radiation Therapy.
What is the best way to schedule an appointment with Kristin Higgins, MD?
Apply for one of the trials that Kristin Higgins, MD is conducting.
What is the office address of Kristin Higgins, MD?
The office of Kristin Higgins, MD is located at: Emory University Hospital Midtown, Atlanta, Georgia 30308 United States. This is the address for their practice at the Emory University Hospital Midtown.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.